These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 28450700)
1. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Van Woensel M; Mathivet T; Wauthoz N; Rosière R; Garg AD; Agostinis P; Mathieu V; Kiss R; Lefranc F; Boon L; Belmans J; Van Gool SW; Gerhardt H; Amighi K; De Vleeschouwer S Sci Rep; 2017 Apr; 7(1):1217. PubMed ID: 28450700 [TBL] [Abstract][Full Text] [Related]
2. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration. Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800 [TBL] [Abstract][Full Text] [Related]
3. Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation. Danhier F; Messaoudi K; Lemaire L; Benoit JP; Lagarce F Int J Pharm; 2015 Mar; 481(1-2):154-61. PubMed ID: 25644286 [TBL] [Abstract][Full Text] [Related]
4. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma. Li C; Guan N; Liu F J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924 [TBL] [Abstract][Full Text] [Related]
5. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme. Kadiyala P; Li D; Nuñez FM; Altshuler D; Doherty R; Kuai R; Yu M; Kamran N; Edwards M; Moon JJ; Lowenstein PR; Castro MG; Schwendeman A ACS Nano; 2019 Feb; 13(2):1365-1384. PubMed ID: 30721028 [TBL] [Abstract][Full Text] [Related]
6. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Le Mercier M; Mathieu V; Haibe-Kains B; Bontempi G; Mijatovic T; Decaestecker C; Kiss R; Lefranc F J Neuropathol Exp Neurol; 2008 May; 67(5):456-69. PubMed ID: 18431251 [TBL] [Abstract][Full Text] [Related]
7. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302 [TBL] [Abstract][Full Text] [Related]
8. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755 [TBL] [Abstract][Full Text] [Related]
9. Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Wang HC; Xia R; Chang WH; Hsu SW; Wu CT; Chen CH; Shih TC Front Immunol; 2024; 15():1372956. PubMed ID: 38953033 [TBL] [Abstract][Full Text] [Related]
10. Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity. Corapi E; Carrizo G; Compagno D; Laderach D Front Immunol; 2018; 9():2190. PubMed ID: 30319642 [TBL] [Abstract][Full Text] [Related]
11. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration. Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220 [TBL] [Abstract][Full Text] [Related]
12. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy. Zhang L; Zhang Y; Wang X; Zhou Y; Qi J; Gu L; Zhao Q; Yu R; Zhou X Small; 2023 Nov; 19(44):e2301439. PubMed ID: 37420326 [TBL] [Abstract][Full Text] [Related]
13. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599 [TBL] [Abstract][Full Text] [Related]
14. Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses. Liu N; Yang X; Gao C; Wang J; Zeng Y; Zhang L; Yin Q; Zhang T; Zhou H; Li K; Du J; Zhou S; Zhao X; Zhu H; Yang Z; Liu Z J Nucl Med; 2024 May; 65(5):728-734. PubMed ID: 38514084 [TBL] [Abstract][Full Text] [Related]